Stock·NASDAQ·Financial Services
IREN Ltd. (IREN)
- Market cap
- $10.64B
- Dividend yield
- 0.00%
- Street target
- $80.00median of 20 analysts
- 52-week range
- $26.55 $76.87
The short version
Where IREN stands today, in four lines, and what CleaRank Financial AI makes of it.
IREN at a glance
IREN Ltd. (IREN): Sell, 27/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($40.99 and $45.37).
- Earnings IREN beat estimates in 4 of its last 8 quarters, yet fell the next day after 2 of those beats.
- Insiders Insiders sold $66.7M and made no open-market purchases over the last 18 months.
Figures as of October 17, 2026.
CleaRank Financial AI
IREN Ltd. (IREN) carries a CleaRank rating of Sell and a model score of 27/100.
Analysts lift the score most: 15 of 20 rate the stock a buy, and the median target is 196.4% above the price. The trend is the largest drag, with the price 40.51% below its 200-day average and 34.16% below its 50-day, and the 50-day 9.65% below the 200-day. The averages stand at $40.99 (50-day) and $45.37 (200-day), and the price has dropped 56.35% over the past year.
Only on CleaRank
Figures we compute ourselves from IREN's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $26.99 is 34.2% below the 50-day simple moving average of $40.99.Price above its 200-day average ›
The price is 40.5% below the 200-day simple moving average of $45.37.50-day average above the 200-day ›
The 50-day average ($40.99) is 9.6% below the 200-day average ($45.37), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 1% of its 52-week range, between $26.55 and $76.87.
IREN share price
Pick a period: each tab shows how far IREN has moved over it, to the last close.
Today's trading
Where IREN sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
0/3P/S below the sector median ›
The price-to-sales ratio of 15.04 is 295.9% above the sector median of 3.8.Profitable over the last 12 months ›
Net income over the last 12 months was $-702.6M on revenue of $707.0M, a net margin of -99.4%.Beat estimates in most recent reports ›
IREN beat the EPS estimate in 4 of its last 8 reports.
Key statistics
The headline figures for IREN.
As of October 17, 2026, IREN trades at $26.99, with a market value of $10.64B and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of IREN's valuation, growth and risks.
IREN Ltd. (IREN) cannot be valued on earnings: its P/E is not meaningful, because the company lost money over the last 12 months. Against sales, the price-to-sales ratio of 15.04 is 295.8% above the sector median of 3.8. The company's market capitalisation stands at $10.6B.
The company is losing money, with a net margin of -99.38% and an operating margin of -102.47%. Growth trails the sector: revenue fell 26.70% in the latest year, against a sector median of 11.7%. It generates a return on equity of -23.41%, below the sector median of 13.8%. Rounding out the fundamentals, IREN reports debt-to-equity of 1.87.
IREN reported earnings on August 27, 2026 and beat the estimate by 44.44%, posting EPS of -$0.25 against the -$0.45 that analysts had expected. Even so, the stock dropped 12.53% in the next session.
Over its last 8 reports, IREN topped the estimate 4 times; even so, 2 of those 4 beats were followed by a lower share price the next session. Earlier, the stock rose 14.93% after the August 28, 2025 report, a miss of 4.55%. The consensus EPS estimate stands at -$3.42 for this fiscal year and -$3.98 for next.
Normal swings for IREN run at about 4.25% a day. Until the price regains its moving averages, the trend works against holders. The price is 64.89% below its 52-week high of $76.87. Insiders sold $66.7M over the last 18 months and bought none on the open market, though sales of this kind are often planned in advance and say less than purchases would.
IREN against the Bitcoin Mining sector
How IREN compares with the median Bitcoin Mining stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, IREN trades at 15.04x, +296% versus the sector average of 3.80x.
Return vs BITQ: Since May 6, 2025, IREN has gained 315.2% against a gain of 12.9% for BITQ.
Performance against BITQ
IREN and the Bitcoin Mining sector fund over the same days.
Revenue and earnings
How much IREN sells, and how much of it becomes profit.
Revenue growth: Revenue grew 165.4% in FY2025 to $501M, from $189M a year earlier.
Profit margin: The net margin was 17.4% in FY2025, up from -15.3% the year before.
Profitable: IREN earned $86.9M in FY2025.
Earnings reality check
Did IREN beat what analysts expected, and how did the stock react?
Earnings record: IREN beat the analyst estimate in 4 of the last 8 quarters.
Market reaction: The stock fell in the first session after 2 of those 4 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 27, 2026after close | -$0.45 | -$0.25 | +44.44% | -12.53% | +2.76% |
| May 8, 2026after close | -$0.26 | -$0.16 | +38.46% | -9.89% | -13.50% |
| Feb 5, 2026after close | -$0.25 | -$0.03 | +88.00% | +5.13% | +0.60% |
| Aug 28, 2025after close | $0.22 | $0.21 | -4.55% | +14.93% | +13.50% |
| May 14, 2025after close | $0.14 | $0.11 | -21.43% | -2.76% | +11.54% |
| Feb 12, 2025after close | $0.06 | $0.09 | +50.00% | +0.54% | -5.00% |
| Nov 26, 2024after close | -$0.07 | -$0.16 | -128.57% | +29.71% | +49.27% |
| Aug 28, 2024after close | $0.03 | -$0.16 | -633.33% | +14.82% | -8.76% |
As of October 17, 2026, IREN has beaten the analyst EPS estimate in 4 of its last 8 reported quarters and fell in the first trading session after 2 of those beats; its latest report, on August 27, 2026, came in 44.44% above the estimate and the stock moved -12.53% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
0/3RSI not overbought or oversold ›
The 14-day RSI is 22.3, in oversold territory.RSI above 50 ›
An RSI of 22.3 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of IREN
The score, the reasoning behind it, and what could move the price next.
IREN is trending down. The stock trades at $26.99, 34.16% below its 50-day average of $40.99 and 40.51% below its 200-day average of $45.37. Its price is 1.66% above the 52-week low of $26.55, which leaves it near the bottom of its 52-week range and 64.89% below the 52-week high of $76.87. The 50-day average is 9.65% below the 200-day average, a gap that backs up the weakness instead of cutting against it.
The 14-day RSI of 22.3 is in oversold territory, and the MACD line is negative. The record is negative across every period shown: the price fell 19.72% over the past three months, fell 43.91% over the past six months and fell 56.35% over the past year.
Earnings beat ›
The August 27, 2026 report beat the EPS estimate by 44.44%, and the share price fell 12.53% in the first session after it.
Source: Earnings report, August 27, 2026New analyst coverage ›
Northland Capital Markets started coverage at Outperform on September 18, 2026.
Source: Analyst action, Northland Capital Markets, September 18, 2026
New analyst coverage ›
Rothschild & Co started coverage at Neutral on September 21, 2026.
Source: Analyst action, Rothschild & Co, September 21, 2026
- Keep an eye on the two closest levels: the 20-day EMA at $37.11, which sits above the price, and the 52-week low at $26.55, which sits below it.
- A 14-day RSI of 22.3 is in oversold territory, and the MACD line is negative. Readings above 70 or below 30 are the usual markers of stretched momentum.
- The share price dropped 12.53% in the first session after the August 27, 2026 report. Across the last 8 reports, IREN has beaten estimates in 4.
IREN sits below its 50-day and 200-day moving averages ($40.99 and $45.37), which keeps the trend down. A first sign of repair would be a move back above the 50-day. The closest level overhead is the 20-day EMA at $37.11.
The next level below the price is the 52-week low of $26.55. The RSI has fallen under the oversold line, which means momentum has been flushed out. If the RSI climbs back above that line, it would be an early hint that the decline is leveling off.
Technical indicators
Momentum and trend for IREN, from its daily closes.
As of October 17, 2026, with IREN at $26.99, its 14-day RSI is 22.3 (oversold territory), its 50-day simple moving average is $40.99 and its 200-day is $45.37.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What IREN moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, IREN's 1-year correlation of daily returns is +0.44 with S&P 500 (SPY), +0.51 with Nasdaq 100 (QQQ), +0.39 with Bitcoin (BTC) and +0.23 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
15 of 20 analysts rate it a buy or strong buy, 5 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $80.00 is 196.4% above the price.More buy ratings than three months ago ›
15 of 20 rate it a buy now, against 12 of 16 three months ago.
IREN Wall Street View
12-month price targets
The price, $26.99, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 29, 2026 | B. Riley Securities | Maintains | Buy |
| Sep 21, 2026 | Rothschild & Co | Initiates | Neutral |
| Sep 18, 2026 | Northland Capital Markets | Initiates | Outperform |
| Sep 14, 2026 | JP Morgan | Upgrade | Overweight |
| Sep 14, 2026 | BTIG | Reiterates | Buy |
| Sep 2, 2026 | Freedom Capital Markets | Maintains | Buy |
As of October 17, 2026, 20 Wall Street analysts cover IREN: 15 rate it a buy or strong buy, 5 a hold and 0 a sell or strong sell. Their 12-month price targets range from $40.00 to $139.00, with a median of $80.00, 196.4% above the price of $26.99.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
IREN trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Short entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
IREN moves about 4.3% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much IREN tends to move, against the market and on its own.
The long record
IREN's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 4.25% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 95.5%, from November 2021 to December 2022, regained by August 2025.Most 1-year holds ended higher ›
77% of 1-year holding periods in the last 5 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in November 2021 is now worth $11,039, against $17,428 in the S&P 500 (SPY).
IREN Drawdowns & Recovery
As of October 17, 2026, IREN's worst peak-to-trough fall over the last 5 years with dividends reinvested was -95.5% (November 2021 to December 2022); it regained that peak by August 2025, 32 months after the low, and 77% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into IREN in November 2021 is worth now, against the same amount in the S&P 500.
Against the market: IREN trailed the S&P 500 over this period: $11,039 against $17,428.
A $10,000 investment in IREN in November 2021 would be worth about $11,039 today with dividends reinvested, compared with about $17,428 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to IREN, and which have not.
Strongest month, June: an average of +16.17%, up in 3 of 5 years.
Weakest month, November: an average of -7.02%, up in 1 of 4 years.
This month, October: has averaged +6.07%, up in 2 of 4 years. Past seasonality does not repeat on schedule.
Over the last 5 years, IREN's strongest calendar month has been June (average +16.17%, up in 3 of 5 years) and its weakest November (average -7.02%, up in 1 of 4 years).
Average return for each calendar month over the last 5 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in IREN, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in IREN today could grow to about $15,237 by 2036 in the base case, with a 90th-percentile outcome near $115,595 and a 10th-percentile outcome around $2,008. Projections are statistical simulations, not guarantees.
IREN Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $31.94 for IREN by 2030 in the base case, from $26.99 today (1.2x over 4 years). The 10th-percentile path ends near $8.87. These are outcomes of a Monte Carlo simulation run on IREN's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $14.83 | $28.15 | $53.43 | |
| 2028 | $11.86 | $29.36 | $72.67 | |
| 2029 | $10.09 | $30.62 | $92.92 | |
| 2030 | $8.87 | $31.94 | $115 | |
| 2031 | $7.95 | $33.32 | $140 |
Method: a lognormal simulation of IREN's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
IREN insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought IREN shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 17, 2026, IREN insiders reported 3 open-market sales worth $66.7M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jul 1, 2026 | Michael Alfred
Director
|
Grant | 6.7K | - |
| Jul 1, 2026 | David James Bartholomew
Director
|
Grant | 8.4K | - |
| Jul 1, 2026 | Christopher Guzowski
Director
|
Grant | 6.7K | - |
| Jul 1, 2026 | Anthony J Lewis
Chief Financial Officer
|
Grant | 27.0K | - |
| Jul 1, 2026 | Sunita Parasuraman
Director
|
Grant | 6.7K | - |
| Jul 1, 2026 | Daniel John Roberts
Chief Executive Officer
|
Grant | 9.7M | - |
| Jul 1, 2026 | William Gregory Roberts
Chief Executive Officer
|
Grant | 9.7M | - |
| Sep 16, 2025 | Christopher Guzowski
Director
|
Sell | 12.0K | $434.3K |
| Sep 11, 2025 | Daniel John Roberts
Chief Executive Officer
|
Sell | 1.0M | $33.1M |
| Sep 11, 2025 | William Gregory Roberts
Chief Executive Officer
|
Sell | 1.0M | $33.1M |
| Jul 1, 2025 | Michael Alfred
Director
|
Grant | 39.2K | - |
| Jul 1, 2025 | David James Bartholomew
Director
|
Grant | 49.0K | - |
| Jul 1, 2025 | Christopher Guzowski
Director
|
Grant | 39.2K | - |
| Jul 1, 2025 | Belinda Nucifora
Chief Financial Officer
|
Grant | 63.9K | - |
| Jul 1, 2025 | Sunita Parasuraman
Director
|
Grant | 39.2K | - |
Source: TwelveData, from reported insider filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.